—

Samsara BioCapital, LLC

Q4 2025 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    21

  • Value ($000)

    $969,257

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001744967
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
S
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$303.84M
31 %

6,897,652

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$213.06M
22 %

5,871,018

---

KALARIS THERAPEUTICS INC

COM
482929106
$109.28M
11 %

12,948,081

---

SEPTERNA INC

COM
81734D104
$87.8M
9 %

3,149,128

A
ALMS

ALUMIS INC

COM
022307102
$56.19M
6 %

5,756,984

N
NGNE

NEUROGENE INC

COM
64135M105
$35.37M
4 %

1,717,127

I
IVA

INVENTIVA SA

ADS
46124U107
$24.16M
3 %

5,194,805

G
GOSS

GOSSAMER BIO INC

COM
38341P102
$22.39M
2 %

7,222,559

---

UPSTREAM BIO INC

COM
91678A107
$19.98M
2 %

736,047

A
AQST

AQUESTIVE THERAPEUTICS INC

COM
03843E104
$16.15M
2 %

2,500,000

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 21